MEDEVA SEMPREX-D (Semprex-D 8 mg-60 mg)
Generic Name: acrivastine/pseudoephedrine
Pill imprint MEDEVA SEMPREX-D has been identified as Semprex-D 8 mg-60 mg.
Semprex-D is used in the treatment of allergic rhinitis; nasal congestion and belongs to the drug class upper respiratory combinations. There is no proven risk in humans during pregnancy. Semprex-D 8 mg-60 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- MEDEVA SEMPREX-D
- 8 mg-60 mg
- Green & White
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Celltech Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
sodium starch glycolate
D&C Yellow No. 10
FD&C Green No. 3
Note: Inactive ingredients may vary.
More about Semprex-D (acrivastine / pseudoephedrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 2 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.